Roche has moved quickly to downplay the significance of top-line results from the first large randomised clinical trial directly comparing the two leading therapies for chronic hepatitis C, Schering-Plough’s Pegintron (peginterferon alfa-2a) and Roche’s own Pegasys (peginterferon alfa-2a).
Read MoreCancer Research UK (CR-UK) is investing £10 million (€13.2 million) in small-molecule drug discovery programmes at four universities across the UK as part of a wider effort to boost the flow of anticancer candidates into clinical trials.
Read MoreIrish contract research organisation (CRO) ICON has broadened its presence in the fast-growing markets of Central and Eastern Europe by opening new offices in Prague (Czech Republic), Kiev (Ukraine) and Bucharest (Romania).
Read MoreA collaborative research facility aimed at advancing medical imaging technology to the benefit of physicians and patients has been set up in the US by computer giant IBM and Mayo Clinic, the not-for-profit medical centre with campuses in Arizona, Florida and Minnesota.
Read MoreThe Association of Clinical Research Organizations (ACRO), the US professional body for companies with a focus on clinical research, has elected David Spaight, president of MDS Pharma Services, as its chair for 2008.
Read More
